Insulet (PODD) EBITDA Margin (2010 - 2026)
Insulet (PODD) posted EBITDA Margin of 16.03% for Q1 2026, down 14.12% on a QoQ basis from 18.67% in Q4 2025, and up 42.0% year-over-year from 11.29% in Q1 2025.
Insulet (PODD) EBITDA Margin (2010 - 2026) Analysis & Trends
Insulet's EBITDA Margin history runs 17 years deep, the most recent figure standing at 16.03% for Q1 2026.
- Quarterly EBITDA Margin rose 42.0% year-over-year to 16.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.48% (up 199.0% YoY) and the FY2025 annual result came in at 17.5%, up 258.0% from the prior year.
- EBITDA Margin was 16.03% for Q1 2026 at Insulet, down from 18.67% in the prior quarter.
- Across five years, EBITDA Margin topped out at 20.89% in Q4 2023 and bottomed at 8.92% in Q2 2022.
- A 5-year average of 12.02% and a median of 12.88% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin tumbled 1904 bps — and 2023, when it jumped 1676 bps.
- Insulet's EBITDA Margin stood at 6.36% in 2022, then jumped by 229 bps to 20.89% in 2023, then declined by 12 bps to 18.29% in 2024, then gained by 2 bps to 18.67% in 2025, then fell by 14 bps to 16.03% in 2026.
- Business Quant data shows PODD's EBITDA Margin at 16.03% in Q1 2026, 18.67% in Q4 2025, and 16.66% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.17% |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 16.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.03% |
| Dec 31, 2025 | 18.67% |
| Sep 30, 2025 | 16.66% |
| Jun 30, 2025 | 18.66% |
| Mar 31, 2025 | 15.61% |
| Dec 31, 2024 | 18.29% |
| Sep 30, 2024 | 16.20% |
| Jun 30, 2024 | 11.16% |
| Mar 31, 2024 | 12.88% |
| Dec 31, 2023 | 20.89% |
| Sep 30, 2023 | 12.66% |
| Jun 30, 2023 | 7.84% |
| Mar 31, 2023 | 7.74% |
| Dec 31, 2022 | 6.36% |
| Sep 30, 2022 | 0.85% |
| Jun 30, 2022 | -8.92% |
| Mar 31, 2022 | 12.83% |
| Dec 31, 2021 | 16.15% |
| Sep 30, 2021 | 12.87% |
| Jun 30, 2021 | 10.12% |